In the last 12 months, insiders at Compass Therapeutics, Inc. ($CMPX) filed 68 transactions with the SEC: 8 open-market purchases totaling $435,600 and 2 sales totaling $11,357,141. Net insider sentiment: net selling.
Compass Therapeutics, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- GORDON CARL L (Director) — 5 transactions totaling $5,678,571
- ORBIMED ADVISORS LLC (Director) — 1 transaction totaling $5,678,571
- Bisker-Leib Vered (Chief Executive Officer) — 2 transactions totaling $3,383,531
- Schuetz Thomas J. (CEO) — 4 transactions totaling $1,546,385
- Shin Barry (CFO) — 5 transactions totaling $1,306,250
View all SEC Filings for Compass Therapeutics, Inc. (CMPX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 8, 2026 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | F | Common Stock | 36687 | $6.52 | 6,603,336.0000 | 177,862,102 | 0.55% | 0.02% |
| Jan. 9, 2026 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | F | Common Stock | 46777 | $5.35 | 6,640,023.0000 | 177,862,102 | 0.70% | 0.03% |
| Jan. 2, 2026 | LINDAHL RICHARD S | Director | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 177,862,102 | 9999.99% | 0.05% |
| Jan. 2, 2026 | Prasad Arjun | Chief Commercial Officer | A | STOCK OPTION (RIGHT TO BUY) | 1000000 | $0.00 | 1,000,000.0000 | 177,862,102 | 9999.99% | 0.56% |
| Jan. 2, 2026 | Schuetz Thomas J. | CEO | A | Stock Option (Right to Buy) | 2000000 | $0.00 | 2,000,000.0000 | 177,862,102 | 9999.99% | 1.12% |
| Jan. 2, 2026 | Schuetz Thomas J. | CEO | A | Common Stock | 250000 | $5.17 | 6,686,800.0000 | 177,862,102 | 3.88% | 0.14% |
| Jan. 2, 2026 | Sirard Cynthia | Chief Medical Officer | A | STOCK OPTION (RIGHT TO BUY) | 1000000 | $0.00 | 1,000,000.0000 | 177,862,102 | 9999.99% | 0.56% |
| Jan. 2, 2026 | Shin Barry | CFO | A | Stock Option (Right to Buy) | 670000 | $0.00 | 670,000.0000 | 177,862,102 | 9999.99% | 0.38% |
| Jan. 2, 2026 | Shin Barry | CFO | A | Common Stock | 125000 | $5.17 | 525,000.0000 | 177,862,102 | 31.25% | 0.07% |
| Jan. 2, 2026 | Lerner Neil | Chief Accounting Officer | A | Common Stock | 62500 | $5.17 | 382,500.0000 | 177,862,102 | 19.53% | 0.04% |
| Jan. 2, 2026 | Chiniara Ellen | Director | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 177,862,102 | 9999.99% | 0.05% |
| Jan. 2, 2026 | Anderman Jonathan | General Counsel | A | Common Stock | 150000 | $5.17 | 171,000.0000 | 177,862,102 | 714.29% | 0.08% |
| Jan. 2, 2026 | Ferneau Philip | Director | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 177,862,102 | 9999.99% | 0.05% |
| Jan. 2, 2026 | GORDON CARL L | Director | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 177,862,102 | 9999.99% | 0.05% |
| Jan. 2, 2026 | Boylan James P | Director | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 177,862,102 | 9999.99% | 0.05% |
| Jan. 2, 2026 | GRAY MARY ANN | Director | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 177,862,102 | 9999.99% | 0.05% |
| Jan. 2, 2026 | Lerner Neil | Chief Accounting Officer | A | Stock Option (Right to Buy) | 435000 | $0.00 | 435,000.0000 | 177,862,102 | 9999.99% | 0.24% |
| Jan. 2, 2026 | Anderman Jonathan | General Counsel | A | Stock Option (Right to Buy) | 720000 | $0.00 | 720,000.0000 | 177,862,102 | 9999.99% | 0.40% |
| Nov. 16, 2025 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | F | Common Stock | 44025 | $4.83 | 6,436,800.0000 | 177,862,102 | 0.68% | 0.02% |
| May 27, 2025 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P | Common Stock | 10000 | $2.11 | 6,480,825.0000 | 138,282,498 | 0.15% | 0.01% |
| April 9, 2025 | ORBIMED ADVISORS LLC | Director | S | Common Stock | 3571428 | $1.59 | 15,219,994.0000 | 138,282,498 | 19.01% | 2.58% |
| April 9, 2025 | GORDON CARL L | Director | S | Common Stock | 3571428 | $1.59 | 15,219,994.0000 | 138,282,498 | 19.01% | 2.58% |
| April 7, 2025 | Anderman Jonathan | Gen Counsel & Corporate Sec | P | Common Stock | 20000 | $1.54 | 21,000.0000 | 138,282,498 | 2000.00% | 0.01% |
| April 7, 2025 | Lerner Neil | CHIEF ACCOUNTING OFFICER | P | Common Stock | 20000 | $1.42 | 320,000.0000 | 138,282,498 | 6.67% | 0.01% |
| Feb. 11, 2025 | Lerner Neil | SVP, CAO | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Shin Barry | CFO | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 1500000 | $0.00 | 1,500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2025 | LINDAHL RICHARD S | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2025 | GRAY MARY ANN | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Ferneau Philip | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Chiniara Ellen | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Anderman Jonathan | Sr VP, Gen Counsel & Corp Sec | A | Stock Option (Right to Buy) | 280000 | $0.00 | 280,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2025 | GORDON CARL L | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Boylan James P | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2025 | Schuetz Thomas J. | CEO | F | Common Stock | 41687 | $3.50 | 6,470,825.0000 | 0 | 0.64% | 0.00% |
| Jan. 9, 2025 | Schuetz Thomas J. | CEO | F | Common Stock | 58054 | $1.86 | 6,512,512.0000 | 0 | 0.88% | 0.00% |
| Dec. 9, 2024 | Shin Barry | CFO | A | Common Stock | 400000 | $1.65 | 400,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 9, 2024 | Shin Barry | CFO | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Anderman Jonathan | Sr VP, Gen Counsel & Corp Sec | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| March 8, 2024 | Boylan James P | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2024 | Chiniara Ellen | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2024 | GRAY MARY ANN | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2024 | LINDAHL RICHARD S | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2024 | GORDON CARL L | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2024 | Ferneau Philip | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Bisker-Leib Vered | CHIEF EXECUTIVE OFFICER | F | Common Stock | 49198 | $1.45 | 3,124,426.0000 | 0 | 1.55% | 0.00% |
| Feb. 8, 2024 | Schuetz Thomas J. | PRESIDENT | F | Common Stock | 44782 | $1.45 | 6,570,566.0000 | 0 | 0.68% | 0.00% |
| Jan. 9, 2024 | Schuetz Thomas J. | President of R&D | A | Stock Option (Right to Buy) | 637500 | $0.00 | 637,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2024 | Schuetz Thomas J. | President of R&D | A | Common Stock | 637500 | $1.93 | 6,615,348.0000 | 0 | 10.66% | 0.00% |
| Jan. 9, 2024 | Bisker-Leib Vered | Chief Executive Officer | A | Stock Option (Right to Buy) | 1753125 | $0.00 | 1,753,125.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2024 | Bisker-Leib Vered | Chief Executive Officer | A | Common Stock | 1753125 | $1.93 | 3,173,624.0000 | 0 | 123.42% | 0.00% |
| Nov. 17, 2023 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | F | Common Stock | 44025 | $1.50 | 5,977,848.0000 | 0 | 0.73% | 0.00% |
| Nov. 17, 2023 | Bisker-Leib Vered | Chief Operating Officer | F | Common Stock | 64415 | $1.50 | 1,420,499.0000 | 0 | 4.34% | 0.00% |
| April 21, 2023 | LINDAHL RICHARD S | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| March 10, 2023 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P | Common Stock | 10000 | $3.37 | 6,021,873.0000 | 0 | 0.17% | 0.00% |
| Feb. 27, 2023 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P | Common Stock | 20000 | $3.98 | 6,011,873.0000 | 0 | 0.33% | 0.00% |
| Feb. 15, 2023 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P | Common Stock | 20000 | $3.86 | 5,991,873.0000 | 0 | 0.33% | 0.00% |
| Feb. 8, 2023 | WURZER DAVID M | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2023 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | A | Common Stock | 500000 | $0.00 | 5,971,873.0000 | 0 | 9.14% | 0.00% |
| Feb. 8, 2023 | GORDON CARL L | Director | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2023 | Ferneau Philip | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2023 | GRAY MARY ANN | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2023 | Chiniara Ellen | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2023 | Bisker-Leib Vered | Chief Operating Officer | A | Stock Option (Right to Buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2023 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 700000 | $0.00 | 700,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2023 | Bisker-Leib Vered | Chief Operating Officer | A | Common Stock | 400000 | $0.00 | 1,484,914.0000 | 0 | 36.87% | 0.00% |
| Jan. 31, 2023 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P | Common Stock | 20000 | $4.05 | 5,471,873.0000 | 0 | 0.37% | 0.00% |
| Jan. 24, 2023 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P | Common Stock | 20000 | $4.19 | 5,451,873.0000 | 0 | 0.37% | 0.00% |